Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors - PubMed (original) (raw)

. 1997 Oct;11(12):1532-3.

H Ruppach, S Gehring, H Knechten, M Knickmann, H Jäger, E Wolf, R Husak, C E Orfanos, H D Brede, H Rübsamen-Waigmann, H von Briesen

• PMID: 9342084

Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors

U Dietrich et al. AIDS. 1997 Oct.

No abstract available

PubMed Disclaimer

Similar articles

• Mutations associated with zidovudine resistance in HIV-1 among recent seroconvertors.
  Quigg M, Rebus S, France AJ, McMenamin J, Darby G, Leigh Brown AJ. Quigg M, et al. AIDS. 1997 May;11(6):835-6. AIDS. 1997. PMID: 9143628 No abstract available.
• Drug resistance mutations as predictors of phenotypic zidovudine resistance in HIV-1 infection.
  Chen P, Schmit JC, Arendt V, Plesseria JM, Lambert C, Fontaine E, Kirpach P, Ninove D, Schneider F, Hemmer R. Chen P, et al. AIDS. 1997 Oct;11(12):1528-9. AIDS. 1997. PMID: 9342081 No abstract available.
• Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
  Kuritzkes DR, Sevin A, Young B, Bakhtiari M, Wu H, St Clair M, Connick E, Landay A, Spritzler J, Kessler H, Lederman MM. Kuritzkes DR, et al. J Infect Dis. 2000 Feb;181(2):491-7. doi: 10.1086/315244. J Infect Dis. 2000. PMID: 10669331 Clinical Trial.
• Overview on HIV-1-related drug resistance: from theory to clinical practice.
  Moroni M, Balotta C, Rusconi S. Moroni M, et al. J Biol Regul Homeost Agents. 1998;12(1-2 Suppl):15-8. J Biol Regul Homeost Agents. 1998. PMID: 9689573 Review. No abstract available.

Cited by

• Integrating laboratory and epidemiological techniques for population-based surveillance of HIV strains and drug resistance in Canada.
  Jayaraman GC, Archibald CP, Lior L, Sutherland D. Jayaraman GC, et al. Can J Infect Dis. 2000 Mar;11(2):74-80. doi: 10.1155/2000/412508. Can J Infect Dis. 2000. PMID: 18159268 Free PMC article. No abstract available.
• Comparison of LCx with other current viral load assays for detecting and quantifying human immunodeficiency virus type 1 RNA in patients infected with the circulating recombinant form A/G (CRF02).
  Amendola A, Bordi L, Angeletti C, Girardi E, Ippolito G, Capobianchi MR. Amendola A, et al. J Clin Microbiol. 2004 Feb;42(2):811-5. doi: 10.1128/JCM.42.2.811-815.2004. J Clin Microbiol. 2004. PMID: 14766858 Free PMC article.
• Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002.
  Jenwitheesuk E, Watitpun C, Vibhagool A, Chantratita W. Jenwitheesuk E, et al. Ann Clin Microbiol Antimicrob. 2003 Mar 6;2:4. doi: 10.1186/1476-0711-2-4. Ann Clin Microbiol Antimicrob. 2003. PMID: 12657161 Free PMC article.
• Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda.
  Mracna M, Becker-Pergola G, Dileanis J, Guay LA, Cunningham S, Jackson JB, Eshleman SH. Mracna M, et al. J Clin Microbiol. 2001 Dec;39(12):4323-7. doi: 10.1128/JCM.39.12.4323-4327.2001. J Clin Microbiol. 2001. PMID: 11724839 Free PMC article. Clinical Trial.
• Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population.
  Gonzales MJ, Machekano RN, Shafer RW. Gonzales MJ, et al. J Infect Dis. 2001 Oct 15;184(8):998-1006. doi: 10.1086/323601. Epub 2001 Sep 10. J Infect Dis. 2001. PMID: 11574914 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information